SWISS BRIDGE AWARD 2026 for young faculty: tumor heterogeneity

SWISS BRIDGE is a private foundation associated with the Swiss Cancer League, the Swiss Cancer Research foundation and the International Union Against Cancer (UICC), and supports high-quality cancer research in Europe.

This year, projects focusing on tumor heterogeneity are eligible for funding.

Applicants should be younger than 45 years of age. 

Funding: 500,000 Swiss francs (~$650,000)
Duration: 3 years

Research Authority due date: 23.4.26

LOI (required) due date: 30.4.26
Full proposal due date: TBD